An adult zebrafish model for preclinical tuberculosis vaccine development

Vaccine

Volumn 31, Issue 45, 2013, Pages 5202-5209

  Oksanen, Kaisa E ^a   Halfpenny, Nicholas J A ^a   Sherwood, Eleanor ^a   Harjula, Sanna Kaisa E ^a   Hammarén, Milka M ^a   Ahava, Maarit J ^a   Pajula, Elina T ^a   Lahtinen, Marika J ^a   Parikka, Mataleena ^a   Rämet, Mika ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

CFU; Dpi; Mycobacterium marinum; Tuberculosis; Vaccine; Wpi; Zebrafish

Indexed keywords

BCG VACCINE; CULTURE FILTRATE PROTEIN 10; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; MYCOBACTERIUM ANTIGEN; PROTEIN AG85B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL COUNT; BCG VACCINATION; CONTROLLED STUDY; DNA IMMUNIZATION; GRANULOMA; MORTALITY; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS; ZEBRA FISH;

CFU; COLONY FORMING UNIT; DAYS POST INFECTION; DPI; MYCOBACTERIUM MARINUM; TUBERCULOSIS; VACCINE; WEEKS POST INFECTION; WPI; ZEBRAFISH;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; SURVIVAL ANALYSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA; ZEBRAFISH;

EID: 84885957815     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.093     Document Type: Article

References (51)

1. World Health Organization Global tuberculosis report 2012, WHO, Geneva.
2. Ottenhoff T.H., Kaufmann S.H. Vaccines against tuberculosis: where are we and where do we need to go?. PLoS Pathog 2012, 8(5):e1002607.
3. Russell D.G., Barry C.E., Flynn J.L. Tuberculosis: what we don't know can, and does, hurt us. Science 2010, 328(5980):852-856.
4. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995, 346(8986):1339-1345.
5. Lin P.L., Dietrich J., Tan E., Abalos R.M., Burgos J., Bigbee C., et al. The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest 2012, 122(1):303-314.
6. Hesseling A.C., Marais B.J., Gie R.P., Schaaf H.S., Fine P.E., Godfrey-Faussett P., et al. The risk of disseminated Bacille Calmette-Guérin (BCG) disease in HIV-infected children. Vaccine 2007, 25(1):14-18.
7. Sambandamurthy V.K., Jacobs W.R. Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis. Microbes Infect 2005, 7(5-6):955-961.
8. Williams A., Hatch G.J., Clark S.O., Gooch K.E., Hatch K.A., Hall G.A., et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinb) 2005, 85(1/2):29-38.
9. Hinchey J., Lee S., Jeon B.Y., Basaraba R.J., Venkataswamy M.M., Chen B., et al. Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. J Clin Invest 2007, 117(8):2279-2288.
10. Cervantes-Villagrana A.R., Hernandez-Pando R., Biragyn A., Castaneda-Delgado J., Bodogai M., Martinez-Fierro M., et al. Prime-boost BCG vaccination with DNA vaccines based in beta-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model. Vaccine 2013, 31(4):676-684.
11. Yuan W., Dong N., Zhang L., Liu J., Lin S., Xiang Z., et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice. Vaccine 2011.
12. Aagaard C., Hoang T., Dietrich J., Cardona P.J., Izzo A., Dolganov G., et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 2011.
13. Acosta A., Norazmi M.N., Hernandez-Pando R., Alvarez N., Borrero R., Infante J.F., et al. The importance of animal models in tuberculosis vaccine development. Malays J Med Sci 2011, 18(4):5-12.
14. Tsenova L., Harbacheuski R., Sung N., Ellison E., Fallows D., Kaplan G. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 2007, 25(28):5126-5132.
15. Skinner M.A., Buddle B.M., Wedlock D.N., Keen D., de Lisle G.W., Tascon R.E., et al. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect Immun 2003, 71(9):4901-4907.
16. Buddle B.M. Vaccination of cattle against Mycobacterium bovis. Tuberculosis (Edinb) 2001, 81(1/2):125-132.
17. Tobin D.M., Ramakrishnan L. Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis. Cell Microbiol 2008, 10(5):1027-1039.
18. Parikka M., Hammaren M.M., Harjula S.K., Halfpenny N.J., Oksanen K.E., Lahtinen M.J., et al. Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish. PLoS Pathog 2012, 8(9):e1002944.
19. Lohi O., Parikka M., Ramet M. The zebrafish as a model for paediatric diseases. Acta Paediatr 2013, 102(2):104-110.
20. Renshaw S.A., Trede N.S. A model 450 million years in the making: zebrafish and vertebrate immunity. Dis Model Mech 2012, 5(1):38-47.
21. Meijer A.H., Spaink H.P. Host-pathogen interactions made transparent with the zebrafish model. Curr Drug Targets 2011, 12:1000-1017.
22. Lieschke G.J., Trede N.S. Fish immunology. Curr Biol 2009, 19(16):R678-R682.
23. Lugo-Villarino G., Balla K.M., Stachura D.L., Banuelos K., Werneck M.B., Traver D. Identification of dendritic antigen-presenting cells in the zebrafish. Proc Natl Acad Sci U S A 2010, 107(36):15850-15855.
24. Stinear T.P., Seemann T., Harrison P.F., Jenkin G.A., Davies J.K., Johnson P.D., et al. Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 2008, 18(5):729-741.
25. Swaim L.E., Connolly L.E., Volkman H.E., Humbert O., Born D.E., Ramakrishnan L. Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity. Infect Immun 2006, 74(11):6108-6117.
26. Cui Z., Samuel-Shaker D., Watral V., Kent M.L. Attenuated Mycobacterium marinum protects zebrafish against mycobacteriosis. J Fish Dis 2010, 33(4):371-375.
27. Matsuda T., Cepko C.L. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc Natl Acad Sci U S A 2004, 101(1):16-22.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
29. Rambabu K.M., Rao S.H., Rao N.M. Efficient expression of transgenes in adult zebrafish by electroporation. BMC Biotechnol 2005, 5:29.
30. Dupuy L.C., Richards M.J., Ellefsen B., Chau L., Luxembourg A., Hannaman D., et al. A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates. Clin Vaccine Immunol 2011, 18(5):707-716.
31. Vasan S., Hurley A., Schlesinger S.J., Hannaman D., Gardiner D.F., Dugin D.P., et al. In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS ONE 2011, 6(5):e19252.
32. Dietrich J., Andersen C., Rappuoli R., Doherty T.M., Jensen C.G., Andersen P. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guérin immunity. J Immunol 2006, 177(9):6353-6360.
33. Kita Y., Okada M., Nakajima T., Kanamaru N., Hashimoto S., Nagasawa T., et al. Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models. Hum Vaccine 2011, 7.
34. Klucar P., Barnes P.F., Kong Y., Howard S.T., Pang X., Huang F.F., et al. Vaccination strategies to enhance local immunity and protection against Mycobacteriun tuberculosis. Vaccine 2009, 27(12):1816-1824.
35. van Dissel J.T., Arend S.M., Prins C., Bang P., Tingskov P.N., Lingnau K., et al. Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naive human volunteers. Vaccine 2010, 28(20):3571-3581.
36. van Dissel J.T., Soonowala D., Joosten S.A., Prins C., Arend S.M., Bang P., et al. Ag85B-ESAT-6 adjuvanted with IC31((R)) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection. Vaccine 2011.
37. Suzuki K., Mori A., Ishii K.J., Saito J., Singer D.S., Klinman D.M., et al. Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A 1999, 96(5):2285-2290.
38. Fletcher H.A. Correlates of immune protection from tuberculosis. Curr Mol Med 2007, 7(3):319-325.
39. Ellis A.E. Innate host defense mechanisms of fish against viruses and bacteria. Dev Comp Immunol 2001, 25(8-9):827-839.
40. Wienholds E., Schulte-Merker S., Walderich B., Plasterk R.H. Target-selected inactivation of the zebrafish rag1 gene. Science 2002, 297(5578):99-102.
41. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17(7):1055-1065.
42. Young S.L., Slobbe L.J., Peacey M., Gilbert S.C., Buddle B.M., de Lisle G.W., et al. Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid-encoded cytokines against Mycobacterium bovis. Immunol Cell Biol 2010, 88(6):651-657.
43. Secombes C.J. Fish immunity: the potential impact on vaccine development and performance. Aquacult Res 2011, 42:90-92.
44. Novoa B., Romero A., Mulero V., Rodriguez I., Fernandez I., Figueras A. Zebrafish (Danio rerio) as a model for the study of vaccination against viral haemorrhagic septicemia virus (VHSV). Vaccine 2006, 24(31/32):5806-5816.
45. Lin J.H., Yu C.C., Lin C.C., Yang H.L. An oral delivery system for recombinant subunit vaccine to fish. Dev Biol (Basel) 2005, 121:175-180.
46. Kilpatrick A.M., Dupuis A.P., Chang G.J., Kramer L.D. DNA vaccination of American robins (Turdus migratorius) against West Nile virus. Vector Borne Zoonotic Dis 2010, 10(4):377-380.
47. McLauchlan P.E., Collet B., Ingerslev E., Secombes C.J., Lorenzen N., Ellis A.E. DNA vaccination against viral haemorrhagic septicaemia (VHS) in rainbow trout: size, dose, route of injection and duration of protection-early protection correlates with Mx expression. Fish Shellfish Immunol 2003, 15(1):39-50.
48. Pasnik D.J., Smith S.A. Immunogenic and protective effects of a DNA vaccine for Mycobacterium marinum in fish. Vet Immunol Immunopathol 2005, 103(3/4):195-206.
49. Pasnik D.J., Smith S.A. Immune and histopathologic responses of DNA-vaccinated hybrid striped bass Morone saxatilis×M. chrysops after acute Mycobacterium marinum infection. Dis Aquat Organ 2006, 73(1):33-41.
50. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev Genet 2008, 9(10):776-788.
51. Liu M.A. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011, 239(1):62-84.